PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-03-02

Date Title Company
02-Mar-2021 Theramex Launches New Website Businesswire
02-Mar-2021 Life Science Analytics Market 2020 Size, Growth Analysis Report, Forecast to 2025 Wired Release
02-Mar-2021 Medical Grade Silicone Market 2020 Size, Growth Analysis Report, Forecast to 2025 Wired Release
02-Mar-2021 Kartesia completes capital increase and acquires 100% stake in ADL Biopharma; Ignacio Urbelz appointed as new CEO ADL Biopharma
02-Mar-2021 Global Nano Healthcare Technology Market 2020, Industry Research Trends, Regional Outlook, Forecast Analysis 2025 Wired Release
02-Mar-2021 Cellulite Treatment Market: Increasing Demand for Minimally Invasive as well as Non-invasive Equipment MARKITWIRED
02-Mar-2021 Sputnik V approved for use in Slovakia Russian Direct Investment Fund
02-Mar-2021 NICE RECOMMENDS BOSTON SCIENTIFIC THERASPHERE™ Y-90 GLASS MICROSPHERES FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA Boston Scientific
02-Mar-2021 Transgene to Present its Immuno-Oncology Expertise at Upcoming Scientific Conferences Transgene
02-Mar-2021 Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products Biomed
02-Mar-2021 Orthokeratology Market Revenue Growth Predicted by 2028 – Future Market Insights MARKITWIRED
02-Mar-2021 COVID risk prediction algorithm achieves UK regulatory approval Sensyne Health plc
02-Mar-2021 Eyenovia Announces FDA Acceptance of the MydCombi NDA Businesswire
02-Mar-2021 GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2020 Businesswire
02-Mar-2021 Canada-US Venture Firm Raiven Capital Welcomes Two New Partners Businesswire
02-Mar-2021 Parkinson’s Disease Therapeutics Market Outlook, Key Financials, Segmental Revenue and Geographical Revenue till 2026 CDN Newswire
02-Mar-2021 Enanta Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
02-Mar-2021 Humanigen Expands its anti-GM-CSF Patent Portfolio Businesswire
02-Mar-2021 Glaukos Announces Participation in Oppenheimer Healthcare Conference Businesswire
02-Mar-2021 Health Canada Approves BRUKINSA® (Zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia Businesswire